These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6313197)

  • 21. Tc-99m pyrophosphate myocardial imaging in acute myocardial infarction: value and limitations.
    Ahmad M
    Mo Med; 1981 Sep; 78(9):575-8. PubMed ID: 6273708
    [No Abstract]   [Full Text] [Related]  

  • 22. [Contribution of cardiac scintigraphy with technetium Tc 99m pyrophosphate and of determination of the ventricular ejection fraction to evaluation of non-transmural acute myocardial infarct].
    Roncari G; Casucci R; Garancini S; Ballada L; Verna E; Bonelli R
    Boll Soc Ital Cardiol; 1981; 26(12):2359-63. PubMed ID: 6309199
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pyrophosphate scan of the heart in cardiomyopathies (author's transl)].
    Duska F; Novák J; Kubícek J; Vizda J; Kafka P; Blaha V; Nesvadba Z; Zdánský P
    Cesk Radiol; 1982 Jan; 36(1):40-7. PubMed ID: 6284387
    [No Abstract]   [Full Text] [Related]  

  • 24. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of EHDP on calcium accumulation and technetium-99m pyrophosphate uptake in experimental myocardial infarction.
    Buja LM; Tofe AJ; Parkey RW; Francis MD; Lewis SE; Kulkarni PV; Bonte FJ; Willerson JT
    Circulation; 1981 Nov; 64(5):1012-7. PubMed ID: 6269777
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of an infarct area using technetium-99m pyrophosphate myocardial scintigraphy].
    Kondo T; Kiriyama T; Kato Y; Kogame Y; Kaneko K; Sakurai M; Hishida H; Mizuno Y; Takeuchi A; Koga S
    J Cardiogr; 1982 Sep; 12(3):699-708. PubMed ID: 6308105
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats.
    Fogelman I; Bessent RG
    Eur J Nucl Med; 1981; 6(5):235. PubMed ID: 6265217
    [No Abstract]   [Full Text] [Related]  

  • 28. [5 years of pyrophosphate scanning of the heart. A set of results from clinical practice].
    Duska F; Novák J; Vizda J; Kafka P; Kubícek J; Veverková O
    Cas Lek Cesk; 1982 Aug; 121(33):1043-6. PubMed ID: 6290068
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental studies of the myocardium by 99mTc-pyrophosphate scanning.
    Sheiretova E; Marinov V; Stoyanova M; Ivanov Z; Kaloyanova A; Kovacheva S
    Radiol Diagn (Berl); 1979 Dec; 20(6):869-75. PubMed ID: 549071
    [No Abstract]   [Full Text] [Related]  

  • 30. Myocardial accumulation of 99Tcm-pyrophosphate and 99Tcm-gluconate compared with morphologic findings in daunorubicin treated rabbits.
    Ahlberg NE; Paul C; Isberg B; Rajs J; Svahn U
    Acta Radiol Diagn (Stockh); 1982; 23(5):463-70. PubMed ID: 6297245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technetium pyrophosphate labelling following catheter shock: potential for a new intraoperative mapping technique.
    Yao LC; Humen DP; Shnitka TK; Trask K; Jugdutt BI
    Can J Cardiol; 1987 Oct; 3(7):326-33. PubMed ID: 2827870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Estimation of the prognosis of patients with ischemic heart disease with the aid of pyrophosphate scanning of the heart muscle].
    Duska F
    Vnitr Lek; 1982 Nov; 28(11):1109-13. PubMed ID: 6297166
    [No Abstract]   [Full Text] [Related]  

  • 33. [Scintiscan diagnosis of acute myocardial infarction using 99mTc-labelled gluconate (author's transl)].
    Duska F; Novák J; Vizda J; Kafka P
    Cas Lek Cesk; 1982 Apr; 121(15):458-61. PubMed ID: 7083290
    [No Abstract]   [Full Text] [Related]  

  • 34. Infarct sizing with Tc-99m pyrophosphate.
    Bianco JA
    J Nucl Med; 1982 Oct; 23(10):939-40. PubMed ID: 6288900
    [No Abstract]   [Full Text] [Related]  

  • 35. [The importance of the current use of pyrophosphate scintigraphy and other noninvasive methods in the detection of cardiac damage in systemic lupus erythematosus].
    Duska F; Bradna P; Pospísil M; Kubícek J; Vizda J; Kafka P; Palicka V; Mazurová Y
    Cas Lek Cesk; 1986 Sep; 125(38-39):1216-9. PubMed ID: 3022930
    [No Abstract]   [Full Text] [Related]  

  • 36. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
    Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
    J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
    [No Abstract]   [Full Text] [Related]  

  • 37. Technetium-99m pyrophosphate scintigraphy in a patient with malignant hyperthermia.
    Murakawa M; Hatano Y; Mori K; Torizuka T; Tamaki N; Iwasaki R
    J Nucl Med; 1989 May; 30(5):718-9. PubMed ID: 2541229
    [No Abstract]   [Full Text] [Related]  

  • 38. Technetium-99m pyrophosphate in diagnosis of acute cardiac rejection in the rat with effect of cyclosporine: concise communication.
    McGregor CG; Hatz R; Aziz S; Billingham MB; McDougall IR
    J Nucl Med; 1984 Aug; 25(8):870-3. PubMed ID: 6086860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial uptake of technetium-99m pyrophosphate in systemic amyloidosis.
    Ptacin MJ
    Am J Cardiol; 1984 Oct; 54(7):938-9. PubMed ID: 6091435
    [No Abstract]   [Full Text] [Related]  

  • 40. [Preliminary clinical use of radionuclide myocardial imaging (author's transl)].
    Liu XJ; Shi RF; Guo XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Sep; 8(3):169-73. PubMed ID: 6273094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.